Table 1.
Characteristics of the Patients | N = 69 | % of the Cohort |
Demographics | ||
Mean age (years) | 6.4 (3.7–9.1) | |
Female | 33 | 47.8 |
Male | 36 | 52.2 |
Ratio male/female | 1.1:1 | |
Clinics | ||
Cutaneous manifestations 1 | 68 | 98.6 |
Joint involvement | 56 | 81.2 |
Gastrointestinal involvement | 26 | 37.7 |
Nephritis | 18 | 26.1 |
Active disease | ||
Beginning of disease | 69 | 100 |
After 3 months | 9 | 13.0 |
After 6 months | 5 | 7.2 |
Treatment | ||
Any treatment | 61 | 88.4 |
Glucocorticoids | 35 | 50.7 |
NSAID 2 | 42 | 60.9 |
Immunosuppressant | 6 | 8.7 |
Antibiotics | 9 | 13.0 |
Other | 48 | 69.6 |
Control Group | N = 33 | % of the Cohort |
Demographics | ||
Mean age (years) | 6.6 (3.8–9.2) | |
Female | 12 | 36.4 |
Male | 21 | 63.6 |
Ratio male/female | 1.75:1 |
1 At the beginning of the disease. 2 NSAID—nonsteroidal anti-inflammatory drugs.